Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

27 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic.
Yepes M, Roussel BD, Ali C, Vivien D. Yepes M, et al. Among authors: roussel bd. Trends Neurosci. 2009 Jan;32(1):48-55. doi: 10.1016/j.tins.2008.09.006. Epub 2008 Oct 27. Trends Neurosci. 2009. PMID: 18963068 Review.
Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates the expression and the release of tissue plasminogen activator (tPA) in neuronal cells: involvement of tPA in the neuroprotective effect of PACAP.
Raoult E, Roussel BD, Bénard M, Lefebvre T, Ravni A, Ali C, Vivien D, Komuro H, Fournier A, Vaudry H, Vaudry D, Galas L. Raoult E, et al. Among authors: roussel bd. J Neurochem. 2011 Dec;119(5):920-31. doi: 10.1111/j.1471-4159.2011.07486.x. Epub 2011 Oct 24. J Neurochem. 2011. PMID: 21919910
Toward safer thrombolytic agents in stroke: molecular requirements for NMDA receptor-mediated neurotoxicity.
Lopez-Atalaya JP, Roussel BD, Levrat D, Parcq J, Nicole O, Hommet Y, Benchenane K, Castel H, Leprince J, To Van D, Bureau R, Rault S, Vaudry H, Petersen KU, Santos JS, Ali C, Vivien D. Lopez-Atalaya JP, et al. Among authors: roussel bd. J Cereb Blood Flow Metab. 2008 Jun;28(6):1212-21. doi: 10.1038/jcbfm.2008.14. Epub 2008 Mar 12. J Cereb Blood Flow Metab. 2008. PMID: 18334994
Recombinant Desmodus rotundus salivary plasminogen activator crosses the blood-brain barrier through a low-density lipoprotein receptor-related protein-dependent mechanism without exerting neurotoxic effects.
López-Atalaya JP, Roussel BD, Ali C, Maubert E, Petersen KU, Berezowski V, Cecchelli R, Orset C, Vivien D. López-Atalaya JP, et al. Among authors: roussel bd. Stroke. 2007 Mar;38(3):1036-43. doi: 10.1161/01.STR.0000258100.04923.84. Stroke. 2007. PMID: 17325305
Tissue-type plasminogen activator rescues neurones from serum deprivation-induced apoptosis through a mechanism independent of its proteolytic activity.
Liot G, Roussel BD, Lebeurrier N, Benchenane K, López-Atalaya JP, Vivien D, Ali C. Liot G, et al. Among authors: roussel bd. J Neurochem. 2006 Sep;98(5):1458-64. doi: 10.1111/j.1471-4159.2006.03982.x. Epub 2006 Jun 27. J Neurochem. 2006. PMID: 16800849
The role of plasminogen activators in stroke treatment: fibrinolysis and beyond.
Thiebaut AM, Gauberti M, Ali C, Martinez De Lizarrondo S, Vivien D, Yepes M, Roussel BD. Thiebaut AM, et al. Among authors: roussel bd. Lancet Neurol. 2018 Dec;17(12):1121-1132. doi: 10.1016/S1474-4422(18)30323-5. Epub 2018 Nov 13. Lancet Neurol. 2018. PMID: 30507392 Review.
Age and albumin D site-binding protein control tissue plasminogen activator levels: neurotoxic impact.
Roussel BD, Macrez R, Jullienne A, Agin V, Maubert E, Dauphinot L, Potier MC, Plawinski L, Castel H, Hommet Y, Munuera J, Montaner J, Yepes M, Ali C, Vivien D. Roussel BD, et al. Brain. 2009 Aug;132(Pt 8):2219-30. doi: 10.1093/brain/awp162. Epub 2009 Jul 2. Brain. 2009. PMID: 19574439 Free PMC article.
PPACK-Desmodus rotundus salivary plasminogen activator (cDSPAalpha1) prevents the passage of tissue-type plasminogen activator (rt-PA) across the blood-brain barrier and neurotoxicity.
Roussel BD, Hommet Y, Macrez R, Schulz T, Petersen KU, Berezowski V, Cecchelli R, Ali C, Vivien D. Roussel BD, et al. Thromb Haemost. 2009 Sep;102(3):606-8. doi: 10.1160/TH09-02-0114. Thromb Haemost. 2009. PMID: 19718485 No abstract available.
HMGB-1 promotes fibrinolysis and reduces neurotoxicity mediated by tissue plasminogen activator.
Roussel BD, Mysiorek C, Rouhiainen A, Jullienne A, Parcq J, Hommet Y, Culot M, Berezowski V, Cecchelli R, Rauvala H, Vivien D, Ali C. Roussel BD, et al. J Cell Sci. 2011 Jun 15;124(Pt 12):2070-6. doi: 10.1242/jcs.084392. Epub 2011 May 24. J Cell Sci. 2011. PMID: 21610098
Antibodies preventing the interaction of tissue-type plasminogen activator with N-methyl-D-aspartate receptors reduce stroke damages and extend the therapeutic window of thrombolysis.
Macrez R, Obiang P, Gauberti M, Roussel B, Baron A, Parcq J, Cassé F, Hommet Y, Orset C, Agin V, Bezin L, Berrocoso TG, Petersen KU, Montaner J, Maubert E, Vivien D, Ali C. Macrez R, et al. Stroke. 2011 Aug;42(8):2315-22. doi: 10.1161/STROKEAHA.110.606293. Epub 2011 Jun 16. Stroke. 2011. PMID: 21680906
27 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback